ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA52 | BioTech | Ofatumumab - 20mg/0.4ml | 10677 | 153320/1 | KESIMPTA | 20mg/0.4ml | 1 | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 96,542,598 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 |